2022
DOI: 10.1136/jmg-2022-108646
|View full text |Cite
|
Sign up to set email alerts
|

Axenfeld-Rieger syndrome: more than meets the eye

Abstract: BackgroundAxenfeld-Rieger syndrome (ARS) is characterised by typical anterior segment anomalies, with or without systemic features. The discovery of causative genes identified ARS subtypes with distinct phenotypes, but our understanding is incomplete, complicated by the rarity of the condition.MethodsGenetic and phenotypic characterisation of the largest reported ARS cohort through comprehensive genetic and clinical data analyses.Results128 individuals with causative variants in PITX2 or FOXC1, including 81 ne… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

3
62
1

Year Published

2022
2022
2024
2024

Publication Types

Select...
7
1

Relationship

2
6

Authors

Journals

citations
Cited by 39 publications
(66 citation statements)
references
References 51 publications
3
62
1
Order By: Relevance
“…This did not reveal any additional pathogenic variants, suggesting the FOXC1 variant was the sole genetic cause of the patient’s disorder. The family was counseled that FOXC1 can be associated with hearing loss, brain anomalies, hypotonia, and failure to thrive in addition to ocular anomalies that would require continuous monitoring [ 15 ]. Heterozygous variants such as the one identified in both the patient and the patient’s mother have been associated with a spectrum of anterior-eye-segment defects, including Axenfeld–Rieger syndrome [ 15 ].…”
Section: Resultsmentioning
confidence: 99%
See 1 more Smart Citation
“…This did not reveal any additional pathogenic variants, suggesting the FOXC1 variant was the sole genetic cause of the patient’s disorder. The family was counseled that FOXC1 can be associated with hearing loss, brain anomalies, hypotonia, and failure to thrive in addition to ocular anomalies that would require continuous monitoring [ 15 ]. Heterozygous variants such as the one identified in both the patient and the patient’s mother have been associated with a spectrum of anterior-eye-segment defects, including Axenfeld–Rieger syndrome [ 15 ].…”
Section: Resultsmentioning
confidence: 99%
“…Genetic testing approaches, uptake, and results were evaluated for all patients with ocular findings who had been evaluated in the clinic (n = 71). Diagnostic rate was evaluated using established American College of Medical Genetics criteria, and compared to other published panel-based testing utilized by other practices, including the Oculome test, Cat-Map testing for cataracts, and anterior segment dysgenesis panel testing [ 14 , 15 , 16 , 17 ].…”
Section: Methodsmentioning
confidence: 99%
“…We describe a patient with features of ASD caused by a novel de novo FOXC1 variant classified as pathogenic and predicted to cause loss of function. Given the frequency of whole FOXC1 gene deletions, haploinsufficiency is a clear mechanism for a FOXC1 -associated disease [ 4 ].…”
Section: Discussionmentioning
confidence: 99%
“…Dominantly inherited mutations in FOXC1 are associated with ASD type 3 (OMIM #601631) and Axenfeld-Rieger syndrome type 3 (OMIM #602482), characterized by additional systemic features of dental abnormalities, craniofacial dysmorphism, and hearing loss [ 3 , 4 ]. FOXC1 encodes Forkhead Box C1, which belongs to the human Forkhead-box (FOX) family, many of which play a vital role in neural crest differentiation [ 5 ].…”
Section: Introductionmentioning
confidence: 99%
“…Later, FOXC1 mutations were discovered in patients with aniridia, Peters anomaly and primary congenital glaucoma (PCG) [4][5][6]. Patients with mutations in FOXC1 often have additional nonocular anomalies, such as heart defects, craniofacial dysmorphisms, hearing loss, skeletal anomalies (hip dysplasia or scoliosis), feeding issues, dental enamel hypoplasia, hypotonia/delay, and white matter lesions in the brain [7][8][9][10][11]. Mutations in FOXC1 explain a high proportion of cases affected with ARS and related…”
Section: Introductionmentioning
confidence: 99%